In NASH, chronic HBV, and HCV, common mechanisms driving HCC development include: the persistence of liver inflammation, immune-mediated liver injury, and ultimately up-regulated release of pro-inflammatory factors TNF-α and IL-6. Here, IL6 is linked to hepatocellular carcinoma.